{"symbol":"ABT","fiscalQuarter":"Q2-2013","reportDate":"2013-07-17","reportTime":"BMO","status":"reported","company":{"name":"Abbott Laboratories","sector":"Health Care","industry":"Health Care Equipment"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/ABT/earnings/Q2-2013","postBrief":{"headline":"Abbott Laboratories Beats on EPS, Stock Up 0.34%","keyNumbers":[{"metric":"EPS","actual":"$0.46","expected":"N/A","surprise":"+4.31%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Unknown","keyQuotes":[],"summary":"No transcript is on record, and the analysis is based solely on numerical results."},"guidanceChanges":{"summary":"No guidance data is available.","changes":[]},"whatItMeans":"Abbott Laboratories reported an earnings per share (EPS) of $0.46, exceeding expectations by 4.31%. However, no revenue figures were disclosed. The stock reacted positively, rising by 0.34%, indicating some investor confidence following the earnings report despite the lack of additional guidance or commentary.","metaDescription":"Abbott Laboratories (ABT) Q2 2013 earnings: EPS beat by 4.31%. Stock up 0.34%. Full breakdown."}}